The University of Chicago Header Logo

Connection

Robert Rosenfield to Child

Back to Details
This is a "connection" page, showing publications Robert Rosenfield has written about Child.
Robert Rosenfield
Connection Strength
0.997
Child
  1. Normal and Premature Adrenarche. Endocr Rev. 2021 11 16; 42(6):783-814.
    View in: PubMed
    Score: 0.093
  2. Commentary: Launch of a quality improvement network for evidence-based management of uncommon pediatric endocrine disorders: Turner syndrome as a prototype. J Clin Endocrinol Metab. 2015 Apr; 100(4):1234-6.
    View in: PubMed
    Score: 0.059
  3. Adolescent polycystic ovary syndrome due to functional ovarian hyperandrogenism persists into adulthood. J Clin Endocrinol Metab. 2015 Apr; 100(4):1537-43.
    View in: PubMed
    Score: 0.058
  4. Comparison of detection of normal puberty in girls by a hormonal sleep test and a gonadotropin-releasing hormone agonist test. J Clin Endocrinol Metab. 2013 Apr; 98(4):1591-601.
    View in: PubMed
    Score: 0.051
  5. Comparison of detection of normal puberty in boys by a hormonal sleep test and a gonadotropin-releasing hormone agonist test. J Clin Endocrinol Metab. 2012 Dec; 97(12):4596-604.
    View in: PubMed
    Score: 0.049
  6. Normal pubertal development: part II: clinical aspects of puberty. Pediatr Rev. 2011 Jul; 32(7):281-92.
    View in: PubMed
    Score: 0.045
  7. Blunted sleep-related luteinizing hormone rise in healthy premenarcheal pubertal girls with elevated body mass index. J Clin Endocrinol Metab. 2009 Apr; 94(4):1168-75.
    View in: PubMed
    Score: 0.038
  8. Thelarche, pubarche, and menarche attainment in children with normal and elevated body mass index. Pediatrics. 2009 Jan; 123(1):84-8.
    View in: PubMed
    Score: 0.038
  9. Improving balance in regulatory oversight of research in children and adolescents: a clinical investigator's perspective. Ann N Y Acad Sci. 2008; 1135:287-95.
    View in: PubMed
    Score: 0.035
  10. Intractable early childhood obesity as the initial sign of insulin resistant hyperinsulinism and precursor of polycystic ovary syndrome. J Pediatr Endocrinol Metab. 2007 Jan; 20(1):41-51.
    View in: PubMed
    Score: 0.033
  11. Clinical review: Identifying children at risk for polycystic ovary syndrome. J Clin Endocrinol Metab. 2007 Mar; 92(3):787-96.
    View in: PubMed
    Score: 0.033
  12. Relationship of adolescent polycystic ovary syndrome to parental metabolic syndrome. J Clin Endocrinol Metab. 2006 Apr; 91(4):1275-83.
    View in: PubMed
    Score: 0.031
  13. A workshop on pubertal hormone replacement options in the United States. J Pediatr Endocrinol Metab. 2006 Jan; 19(1):55-64.
    View in: PubMed
    Score: 0.031
  14. Salutary effects of combining early very low-dose systemic estradiol with growth hormone therapy in girls with Turner syndrome. J Clin Endocrinol Metab. 2005 Dec; 90(12):6424-30.
    View in: PubMed
    Score: 0.030
  15. Current age of onset of puberty. Pediatrics. 2000 Sep; 106(3):622-3.
    View in: PubMed
    Score: 0.021
  16. Optimizing estrogen replacement in adolescents with Turner syndrome. Ann N Y Acad Sci. 2000; 900:213-4.
    View in: PubMed
    Score: 0.020
  17. Diagnosis of the polycystic ovary syndrome in adolescence: comparison of adolescent and adult hyperandrogenism. J Pediatr Endocrinol Metab. 2000; 13 Suppl 5:1285-9.
    View in: PubMed
    Score: 0.020
  18. Optimizing estrogen replacement treatment in Turner syndrome. Pediatrics. 1998 Aug; 102(2 Pt 3):486-8.
    View in: PubMed
    Score: 0.018
  19. Estrogen Replacement in Turner Syndrome: Literature Review and Practical Considerations. J Clin Endocrinol Metab. 2018 05 01; 103(5):1790-1803.
    View in: PubMed
    Score: 0.018
  20. Physician and clinic charges for diagnosing growth hormone deficiency. J Pediatr. 1996 May; 128(5 Pt 2):S61-2.
    View in: PubMed
    Score: 0.016
  21. Maturation of the normal pituitary-testicular axis, as assessed by gonadotropin-releasing hormone agonist challenge. J Clin Endocrinol Metab. 1994 Jun; 78(6):1336-40.
    View in: PubMed
    Score: 0.014
  22. Selection of children with precocious puberty for treatment with gonadotropin releasing hormone analogs. J Pediatr. 1994 Jun; 124(6):989-91.
    View in: PubMed
    Score: 0.014
  23. Normal and almost normal precocious variations in pubertal development premature pubarche and premature thelarche revisited. Horm Res. 1994; 41 Suppl 2:7-13.
    View in: PubMed
    Score: 0.013
  24. Potential of gonadotropin-releasing hormone agonists in the diagnosis of pubertal disorders in girls. Clin Obstet Gynecol. 1993 Sep; 36(3):773-85.
    View in: PubMed
    Score: 0.013
  25. Height prognosis of children with true precocious puberty and growth hormone deficiency: effect of combination therapy with gonadotropin releasing hormone agonist and growth hormone. J Pediatr. 1992 May; 120(5):709-15.
    View in: PubMed
    Score: 0.012
  26. Hyperandrogenism in peripubertal girls. Pediatr Clin North Am. 1990 Dec; 37(6):1333-58.
    View in: PubMed
    Score: 0.011
  27. Clinical review 6: Diagnosis and management of delayed puberty. J Clin Endocrinol Metab. 1990 Mar; 70(3):559-62.
    View in: PubMed
    Score: 0.010
  28. Growth hormone deficiency impedes the rise in plasma insulin-like growth factor I levels associated with precocious puberty. J Pediatr. 1989 Jul; 115(1):64-8.
    View in: PubMed
    Score: 0.010
  29. Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics. 2009 Apr; 123(4):e752-62.
    View in: PubMed
    Score: 0.010
  30. Paternal deletion 6q24.3: a new congenital anomaly syndrome associated with intrauterine growth failure, early developmental delay and characteristic facial appearance. Am J Med Genet A. 2008 Feb 01; 146A(3):354-60.
    View in: PubMed
    Score: 0.009
  31. The rapid ovarian secretory response to pituitary stimulation by the gonadotropin-releasing hormone agonist nafarelin in sexual precocity. J Clin Endocrinol Metab. 1986 Dec; 63(6):1386-9.
    View in: PubMed
    Score: 0.008
  32. Pubertal data for growth velocity charts. J Pediatr. 1986 Sep; 109(3):564-5.
    View in: PubMed
    Score: 0.008
  33. Functional significance of polycystic-size ovaries in healthy adolescents. J Clin Endocrinol Metab. 2006 Oct; 91(10):3786-90.
    View in: PubMed
    Score: 0.008
  34. Low-dose testosterone effect on somatic growth. Pediatrics. 1986 Jun; 77(6):853-7.
    View in: PubMed
    Score: 0.008
  35. The changing ratio of bioactive to immunoreactive luteinizing hormone (LH) through puberty principally reflects changing LH radioimmunoassay dose-response characteristics. J Clin Endocrinol Metab. 1985 Sep; 61(3):508-13.
    View in: PubMed
    Score: 0.008
  36. Dexamethasone preparation does not alter corticoid and androgen responses to adrenocorticotropin. J Clin Endocrinol Metab. 1985 Mar; 60(3):585-9.
    View in: PubMed
    Score: 0.007
  37. GnRH agonist stimulation of the pituitary-gonadal axis in children: age and sex differences in circulating inhibin-B and activin-A. Hum Reprod. 2004 Dec; 19(12):2748-58.
    View in: PubMed
    Score: 0.007
  38. Advances in diagnosis and treatment of short stature, with special reference to the role of growth hormone. J Pediatr. 1984 Jun; 104(6):801-13.
    View in: PubMed
    Score: 0.007
  39. Puberty in girls born to infertile women after gonadotropin therapy. JAMA. 1983 Dec 16; 250(23):3201.
    View in: PubMed
    Score: 0.007
  40. Plasma free testosterone in the diagnosis of adolescent polycystic ovary syndrome. J Pediatr. 1983 Mar; 102(3):461-4.
    View in: PubMed
    Score: 0.006
  41. Adrenarche as a cause of benign pseudopuberty in boys. J Pediatr. 1982 Dec; 101(6):1005-9.
    View in: PubMed
    Score: 0.006
  42. Amenorrhea related to progestin excess in congenital adrenal hyperplasia. Obstet Gynecol. 1980 Aug; 56(2):208-15.
    View in: PubMed
    Score: 0.005
  43. Testosterone binding and free plasma androgen concentrations under physiological conditons: chararacterization by flow dialysis technique. J Clin Endocrinol Metab. 1979 Nov; 49(5):730-6.
    View in: PubMed
    Score: 0.005
  44. Gonadotropin-releasing hormone infusion test in the distinction of hypopituitary patients from normal subjects. Fertil Steril. 1979 May; 31(5):507-12.
    View in: PubMed
    Score: 0.005
  45. Oxandrolone therapy for children with Turner syndrome. J Pediatr. 1977 Nov; 91(5):854-6.
    View in: PubMed
    Score: 0.004
  46. Partial growth-hormone insensitivity: the role of growth-hormone receptor mutations in idiopathic short stature. J Pediatr. 1997 Jul; 131(1 Pt 2):S51-5.
    View in: PubMed
    Score: 0.004
  47. Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. J Clin Endocrinol Metab. 1994 Nov; 79(5):1328-33.
    View in: PubMed
    Score: 0.004
  48. The response to human chorionic gonadotropin (HCG) administration in boys with and without delta5-3beta-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab. 1974 Aug; 39(2):370-4.
    View in: PubMed
    Score: 0.004
  49. Managing delayed puberty. Postgrad Med. 1972 May; 51(5):204-9.
    View in: PubMed
    Score: 0.003
  50. Isosexual pseudoprecocity in a 6-year-old boy with a testicular interstitial cell adenoma. J Pediatr. 1972 Feb; 80(2):264-8.
    View in: PubMed
    Score: 0.003
  51. Plasma 17-ketosteroids and 17-beta hydroxysteroids in girls with premature development of sexual hair. J Pediatr. 1971 Aug; 79(2):260-6.
    View in: PubMed
    Score: 0.003
  52. Plasma 17-ketosteroids and testosterone in prepubertal children before and after ACTH administration. J Clin Endocrinol Metab. 1971 Aug; 33(2):249-53.
    View in: PubMed
    Score: 0.003
  53. Preserving adult height potential in girls with idiopathic true precocious puberty. J Pediatr. 1990 Sep; 117(3):364-70.
    View in: PubMed
    Score: 0.003
  54. Plasma 17-ketosteroid levels during adolescence. J Pediatr. 1969 Jun; 74(6):932-6.
    View in: PubMed
    Score: 0.002
  55. Sex hormone-binding globulin in the diagnosis of peripheral tissue resistance to thyroid hormone: the value of changes after short term triiodothyronine administration. J Clin Endocrinol Metab. 1988 Apr; 66(4):740-6.
    View in: PubMed
    Score: 0.002
  56. A longitudinal study of the relationship of plasma somatomedin-C concentration to the pubertal growth spurt. Am J Dis Child. 1987 May; 141(5):562-4.
    View in: PubMed
    Score: 0.002
  57. Administration of low-dose estrogen rapidly and directly stimulates growth hormone production. Am J Dis Child. 1986 Feb; 140(2):124-7.
    View in: PubMed
    Score: 0.002
  58. Adrenarche: changing adrenal response to adrenocorticotropin. J Clin Endocrinol Metab. 1981 Jun; 52(6):1129-36.
    View in: PubMed
    Score: 0.001
  59. LH bioactivity increases more than immunoreactivity during puberty. J Pediatr. 1980 Aug; 97(2):205-13.
    View in: PubMed
    Score: 0.001
  60. Bioactive LH: a test to discriminate true precocious puberty from premature thelarche and adrenarche. J Pediatr. 1980 Aug; 97(2):214-6.
    View in: PubMed
    Score: 0.001
  61. Growth retardation and zinc nutrition. Pediatr Res. 1976 Nov; 10(11):923-7.
    View in: PubMed
    Score: 0.001
  62. The levodopa test of growth hormone reserve in children. Am J Dis Child. 1973 Nov; 126(5):589-92.
    View in: PubMed
    Score: 0.001
  63. Sequential changes in beta-cell function in insulin-treated diabetic patients assessed by C-peptide immunoreactivity. N Engl J Med. 1973 May 31; 288(22):1144-8.
    View in: PubMed
    Score: 0.001
  64. The plasma growth hormone response to insulin-induced hypoglycemia in children with retardation of growth. Pediatrics. 1967 Jun; 39(6):844-52.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.